164 related articles for article (PubMed ID: 33867420)
1. Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT.
Arai H; Bujo H; Masuda D; Ishibashi T; Nakagawa S; Tanabe K; Kagimura T; Kang HJ; Kim MH; Sung J; Kim SH; Kim CH; Park JE; Ge J; Oh BH; Kita T; Saito Y; Fukushima M; Matsuzawa Y; Yamashita S
J Atheroscler Thromb; 2022 Jun; 29(6):850-865. PubMed ID: 33867420
[TBL] [Abstract][Full Text] [Related]
2. Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease.
Yamashita S; Masuda D; Ohama T; Arai H; Bujo H; Kagimura T; Kita T; Matsuzaki M; Saito Y; Fukushima M; Matsuzawa Y;
J Atheroscler Thromb; 2016 Jun; 23(6):746-56. PubMed ID: 26803913
[TBL] [Abstract][Full Text] [Related]
3. Effect of Probucol and/or Cilostazol on Carotid Intima Media Thickness in Patients with Coronary Heart Disease: A Randomized, Multicenter, Multinational Study.
Kang HJ; Kim MH; Sung J; Kim SH; Kim CH; Park JE; Ge J; Oh BH;
J Atheroscler Thromb; 2021 Feb; 28(2):124-136. PubMed ID: 32336696
[TBL] [Abstract][Full Text] [Related]
4. Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE).
Yamashita S; Arai H; Bujo H; Masuda D; Ohama T; Ishibashi T; Yanagi K; Doi Y; Nakagawa S; Yamashiro K; Tanabe K; Kita T; Matsuzaki M; Saito Y; Fukushima M; Matsuzawa Y;
J Atheroscler Thromb; 2021 Feb; 28(2):103-123. PubMed ID: 32336695
[TBL] [Abstract][Full Text] [Related]
5. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).
Sawayama Y; Shimizu C; Maeda N; Tatsukawa M; Kinukawa N; Koyanagi S; Kashiwagi S; Hayashi J
J Am Coll Cardiol; 2002 Feb; 39(4):610-6. PubMed ID: 11849859
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
Tardif JC; Grégoire J; Lavoie MA; L'Allier PL
Curr Opin Lipidol; 2003 Dec; 14(6):615-20. PubMed ID: 14624139
[TBL] [Abstract][Full Text] [Related]
7. Effect of probucol on elderly hypercholesterolemic patients in the FAST study.
Sawayama Y; Maeda S; Ohnishi H; Okada K; Hayashi J
Fukuoka Igaku Zasshi; 2006 Jan; 97(1):15-24. PubMed ID: 16613215
[TBL] [Abstract][Full Text] [Related]
8. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.
Sawayama Y; Okada K; Maeda S; Ohnishi H; Furusyo N; Hayashi J
Fukuoka Igaku Zasshi; 2006 Aug; 97(8):245-55. PubMed ID: 17087362
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with probucol improves endothelial function in patients with coronary artery disease.
Tagawa T; Urabe Y; Kimura Y; Suzuki S; Ono H; Takeda K
Hypertens Res; 2004 May; 27(5):311-8. PubMed ID: 15198477
[TBL] [Abstract][Full Text] [Related]
10. Design and Rationale of the Intima-Medial Thickness Sub-Study of the PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral hemOrrhage (PICASSO-IMT) Study.
Seo WK; Kim YJ; Lee J; Kwon SU;
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1892-1898. PubMed ID: 28739344
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
12. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
Shukla A; Sharma MK; Jain A; Goel PK
Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
[TBL] [Abstract][Full Text] [Related]
14. Probucol therapy improves long-term (>10-year) survival after complete revascularization: a propensity analysis.
Kasai T; Miyauchi K; Kubota N; Kajimoto K; Amano A; Daida H
Atherosclerosis; 2012 Feb; 220(2):463-9. PubMed ID: 22024277
[TBL] [Abstract][Full Text] [Related]
15. [Influence of low high-density lipoprotein cholesterolemia induced by probucol on the progression of coronary atherosclerosis].
Takahashi T; Hiasa Y; Harada S; Hosokawa S; Kato S; Tanimoto M; Kishi K; Ohtani R
J Cardiol; 1997 Aug; 30(2):67-72. PubMed ID: 9300286
[TBL] [Abstract][Full Text] [Related]
16. Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan.
Yamashita S; Bujo H; Arai H; Harada-Shiba M; Matsui S; Fukushima M; Saito Y; Kita T; Matsuzawa Y
J Atheroscler Thromb; 2008 Dec; 15(6):292-303. PubMed ID: 19060422
[TBL] [Abstract][Full Text] [Related]
17. Effects of combination therapy with cilostazol and probucol versus monotherapy with cilostazol on coronary plaque, lipid and biomarkers: SECURE study, a double-blind randomized controlled clinical trial.
Ko YG; Choi SH; Chol Kang W; Kwon Lee B; Wook Kim S; Shim WH
J Atheroscler Thromb; 2014; 21(8):816-30. PubMed ID: 24705623
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study.
Tanaka A; Yoshida H; Nanasato M; Oyama JI; Ishizu T; Ajioka M; Ishiki R; Saito M; Shibata Y; Kaku K; Maemura K; Higashi Y; Inoue T; Murohara T; Node K
Int J Cardiol; 2018 Nov; 271():331-335. PubMed ID: 29803341
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of probucol in hypercholesteremia: individual lipoprotein responses and inhibitory effect on carotid atherosclerosis progression.
Baldassarre D; Franceschini G; Peruzzotti G; Brusoni B; Sirtori CR
J Cardiovasc Pharmacol; 1997 Dec; 30(6):784-9. PubMed ID: 9436818
[TBL] [Abstract][Full Text] [Related]
20. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).
Daida H; Kuwabara Y; Yokoi H; Nishikawa H; Takatsu F; Nakata Y; Kutsumi Y; Oshima S; Nishiyama S; Ishiwata S; Kato K; Nishimura S; Miyauchi K; Kanoh T; Yamaguchi H
Am J Cardiol; 2000 Sep; 86(5):550-2, A9. PubMed ID: 11009277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
